BCAX

BICARA THERAPEUTICS INC

BCAX·055477103·US·Common Stock·Healthcare - Biotechnology-Activist

BCAX (BICARA THERAPEUTICS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($144.3M), Janus Henderson Group Ltd. ($66.4M), BlackRock, Inc. ($56.6M). Net institutional sentiment: Mixed.

88
Holders
Avg rating(19 Elite)
$621.8M
Total Value
55% (96)
Fund Consensus
49 buying - 40 selling
BCAXSmart Money Verdict
View all
Held by 88 funds
19 elite
Who's Trading
InsiderMCMazumdar ClaireSell $283KJul 10, 2026
InsiderMCMazumdar ClaireSell $831.04Jul 10, 2026
InsiderCRCohlhepp RyanSell $16KJul 9, 2026
InsiderCRCohlhepp RyanSell $657KJul 8, 2026
InsiderCRCohlhepp RyanSell $128KJul 8, 2026
InsiderCRCohlhepp RyanSell $33KJul 8, 2026
InsiderHIHyep IvanSell $651KJul 8, 2026
InsiderHIHyep IvanSell $132KJul 8, 2026
ActivistDTDeep Track Capital, LP6.2%May 15, 2026
ActivistVPVestal Point Capital, LP8.3%May 15, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.3M(+4.3%)$144.3M1.5%+15.05%
50
Increased
3.3M(+26.2%)$66.4M0.0%+75.34%
36
Increased
2.8M(+12.5%)$56.6M0.0%+99.80%
33
Decreased
2.1M(-37.2%)$41.8M0.0%+85.92%
0
New
1.8M$35.3M0.0%+61.33%
40
Increased
1.7M(+114.9%)$33M0.0%+69.24%
47
Increased
1.6M(+0.1%)$32.3M0.0%+79.32%
29
Decreased
1.4M(-13.9%)$28.2M0.0%+88.47%
0
Decreased
1.4M(-11.8%)$27.4M0.0%+35.97%
0
Increased
830,906(+2.4%)$16.5M0.0%+92.05%
29
Decreased
679,904(-10.4%)$13.5M0.0%+13.64%
0
Increased
558,964(+1.2%)$11.1M0.0%+84.53%
28
Increased
421,219(+284.8%)$8.4M0.0%+68.98%
44
Unchanged
401,444$8M0.0%+79.34%
0
Decreased
327,989(-2.3%)$6.5M0.0%+215.95%
0
New
290,939$5.8M0.0%+61.33%
38
Decreased
289,221(-3.2%)$5.8M0.0%+108.44%
0
Increased
276,943(+102.9%)$5.5M0.0%+69.73%
44
Increased
269,718(+10.3%)$5.4M0.0%+71.60%
30
Decreased
263,985(-3.0%)$5.3M0.0%+94.82%
0

Showing 1-20 of 96

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used